1. Detection of Lung Cancer and EGFR Mutation by Electronic Nose System
Dekel Shlomi, MD, Manal Abud, MSc, Ori Liran, MD, Jair Bar, MD, Naomi Gai-Mor, MSc, Maya Ilouze, PhD, Amir Onn, MD, Alon Ben- Nun, MD, Hossam Haick, PhD, Nir Peled, MD, PhD 
Journal of Thoracic Oncology 
Volume 12, Issue 10, Pages (October 2017)
DOI: /j.jtho
Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

2. Figure 1
Discriminant factor analysis plots calculated from the responses of the nanoarray sensors for benign pulmonary nodules and early lung cancer. Each point represents one patient. The positions of the mean values are marked with an unfilled square, the boxes correspond to the first and third quartiles, and the error bars correspond to the SDs. CV1, first canonical variable (see Text).
Journal of Thoracic Oncology  , DOI: ( /j.jtho )
Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

3. Figure 2
Discriminant factor analysis plot calculated from the responses of the nanoarray sensors for patients with lung cancer with and without the EGFR mutation. Each point represents one patient. The positions of the mean values are marked with an unfilled square, the boxes correspond to the first and third quartiles, and the error bars correspond to the SDs. CV1, first canonical variable (see Text).
Journal of Thoracic Oncology  , DOI: ( /j.jtho )
Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions